OFI Building Blocks: Creating Relevant Brands

This program is currently sold out. Program details can be viewed below:

Defining and developing your brand – it’s more than just a name

When most companies, especially early stage companies, consider their brands they think about picking a really cool name and then check branding off of their to-do list. But a brand is so much more than just a name. To be valuable to customers, investors, and potential partners, your brand has to be relevant. This DevicePharm presentation will provide a guide to creating company and product brands that are not only relevant, but provide differentiation, energy, leverage, and clarity as well.

Featured Speakers:

CLAY WILEMON – Chief Executive & Chief Strategy Officer

William C. “Clay” Wilemon is Chief Executive & Chief Strategy Officer of DevicePharm, Inc. He established the company, originally known as Health Communications, Inc., in 1990.

 Clay is a graduate of Vanderbilt University and has over 20 years of experience in healthcare marketing with medical device and pharmaceutical companies as well as hospitals, medical groups and managed care organizations. Prior to 1985, he worked in marketing with the Frito-Lay division of PepsiCo.

 Clay has provided strategic marketing counsel to three publicly traded companies during their start-up periods. In addition, he was co-founder and a Board Member of HealthyMe.md, an Internet-based health information company that is now part of the Challenger Corporation.

 Clay has been a speaker on healthcare marketing around the nation and has been a guest university lecturer. He’s the founder of the Third Day Media Foundation, serves on the Capital Campaign Board for the new Eye Institute at the University of California, Irvine, and is President of South Coast Youth Basketball. In years past, he has served on the Board of The Children’s Museum of Memphis and the World Cataract Foundation.

JON HERMIE, MBA – President

Jon Hermie serves as DevicePharm’s President. He’s a graduate of the University of Iowa and the Kellogg School of Business at Northwestern University.

 Prior to joining DevicePharm, Jon held positions as Chief Operating Officer and Executive Vice President of a healthcare marketing firm specializing in celebrity-based public relations, advertising and Internet media. Jon directed campaigns for companies such as Pfizer, Guidant, Merck, Aventis, Tenet Healthcare, Inamed, Genzyme, Aspect Medical, and the Pharmaceutical Research and Manufacturers of America.

 Previously, Jon was a member of the start-up team at Luminant Worldwide, a firm delivering Internet based business solutions for healthcare and financial services firms. In addition, Jon has served as a marketing consultant with Deloitte Consulting where he practiced strategy, marketing and financial consulting for several years.

DevicePharm Overview

DevicePharm is an Irvine, California based provider of marketing strategy and integrated marketing communications solutions for organizations serving medical professionals and healthcare consumers. Our clients include medical device, biotech, life science, and pharmaceutical firms ranging from venture-backed start-ups to established market leaders with over $1B in annual revenue. The DevicePharm team of marketing, creative, multimedia, and medical professionals provides clients with:

§  Award-winning professional advertising and direct marketing,

§  Award-winning practitioner and consumer focused web and e-media design,

§  Comprehensive medical education under the direction of an MD,

§  Direct-to-consumer and physician-to-consumer programs featured in the Wall Street Journal and other business media. 

§  Demonstrated success in creating new markets by generating physician and consumer demand for elective medical procedures.

Clay Wilemon, Chief Executive & Chief Strategy Officer and Jon Hermie, President; lead the DevicePharm team. To get the DevicePharm perspective on your marketing needs, call 949.271.1180 or email AerielleN@DevicePharm.com.

Space is Limited. No Walk-Ins Please.

Sponsored By: DevicePharm, Pacific Life Foundation, & OFI.